PharmiNews

Directory of Pharma Companies and News

Company Profile

Arvelle Therapeutics GmbH

Arvelle Therapeutics GmbH logo
Category
Arvelle Therapeutics is an emerging biopharmaceutical company focused on bringing innovative solutions to patients suffering from CNS disorders. Arvelle is responsible for the development and commercialization of cenobamate, an investigational antiepileptic drug, in the European market. Arvelle is headquartered in Switzerland and received start-up financing of $207.5 million, one of the largest initial financing commitments for a European-‐focused biopharmaceutical company, with investments from a global syndicate including NovaQuest Capital Management, BRV Capital Management, LSP, H.I.G. BioHealth Partners, Andera Partners, F-Prime Capital and KB Investments.
Keywords:
0 results
Brought to you by PharmiWeb.com - Latest Jobs in Pharma